Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and visual function effects of 0.01% atropine for myopia inhibition in children and adolescents
2017-002588-17Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Jun 2019
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atropine in myopia, sponsored by University Hospital Tübingen. Primary endpoint: Amplitude of accommodation. Started Jun 2019; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on 2017-002588-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002588-17.